Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of antibody drugs. The company develops medicines which combines capabilities of monoclonal antibodies with the cancer-killing ability of cytotoxic drugs.
You’re viewing a free company profile from the PitchBook Platform. To explore Wntrix’s full profile, request a free trial.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.